KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma https://www.mesothelioma-line.....com/keynote-a17-firs
Discover the world at Altruu, The Discovery Engine
KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma https://www.mesothelioma-line.....com/keynote-a17-firs
Epithelial-Mesenchymal Plasticity in the D-Meso-Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial-Mesenchymal Transition in Mesothelioma https://www.mesothelioma-line.....com/epithelial-mesen
From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma https://www.mesothelioma-line.....com/from-asbestos-ex
A bibliometric analysis of malignant pleural mesothelioma from 2010 to 2023 https://www.mesothelioma-line.....com/a-bibliometric-a
Diagnostic value of cyclin D1 immunohistochemistry in differentiating malignant mesothelioma from reactive mesothelial proliferation https://www.mesothelioma-line.....com/diagnostic-value